Interaction between CCK and a preload on reduction of food intake is mediated by CCK-A receptors in humans.
Cholecystokinin (CCK) interacts with neural signals to induce satiety in several species, but the mechanisms are unclear. We therefore tested the hypothesis that alimentary CCK (CCK-A) receptors mediate the interaction of CCK with an appetizer on food intake in humans. CCK octapeptide (CCK-8, 0.75 microgram infused over 10 min) or saline (placebo) with concomitant infusions of saline (placebo) or loxiglumide, a specific CCK-A antagonist, was infused into 16 healthy men with use of a double-blind, four-period design. All subjects received a standard 400-ml appetizer (amounting to 154 kcal) but were free to eat and drink thereafter as much as they wished. The effect of these infusions on feelings of hunger and satiety and on food intake was quantified. CCK-8 induced a reduction in calorie intake (P < 0.05) compared with saline. Furthermore, a decrease in hunger feelings (P < 0.05, saline-CCK-8 vs. all other treatments) and an increase in fullness were observed. These effects were antagonized for hunger and fullness by loxiglumide. We conclude that CCK-8 interacts with an appetizer to modulate satiety in humans. These effects are mediated by CCK-A receptors.
Gutzwiller
J P
JP
Division of Gastroenterology and Department of Research, University Hospital, CH-4031 Basel, Switzerland.
Drewe
J
J
Ketterer
S
S
Hildebrand
P
P
Krautheim
A
A
Beglinger
C
C
D000328:Adult; D002766:Cholecystokinin / Q000097:blood*; D018592:Cross-Over Studies; D004311:Double-Blind Method; D004435:Eating / Q000187:drug effects / Q000502:physiology*; D002149:Energy Intake / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006815:Hunger / Q000187:drug effects / Q000502:physiology; D007262:Infusions, Intravenous; D008297:Male; D011377:Proglumide / Q000008:administration & dosage / Q000031:analogs & derivatives*; D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012528:Satiety Response / Q000187:drug effects / Q000502:physiology*; D012844:Sincalide / Q000008:administration & dosage
D043886:Receptor, Cholecystokinin A; D011949:Receptors, Cholecystokinin; C053737:loxiglumide; D002766:Cholecystokinin; D011377:Proglumide; D012844:Sincalide